3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one

C22H24N10O12P2S2 — CID 137303418

IUPAC3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one
SMILESNc1nc2c(ncn2[C@@H]2O[C@@H]3COP(O)(=S)O[C@H]4[C@@H](O)[C@H](n5cnc6c(=O)n7ccnc7[nH]c65)O[C@@H]4COP(=O)(S)O[C@H]3[C@H]2O)c(=O)[nH]1
InChIInChI=1S/C22H24N10O12P2S2/c23-21-27-15-9(17(35)29-21)25-5-31(15)19-11(33)13-7(41-19)3-39-46(38,48)44-14-8(4-40-45(37,47)43-13)42-20(12(14)34)32-6-26-10-16(32)28-22-24-1-2-30(22)18(10)36/h1-2,5-8,11-14,19-20,33-34H,3-4H2,(H,24,28)(H,37,47)(H,38,48)(H3,23,27,29,35)/t7-,8-,11-,12-,13-,14-,19-,20-,45?,46?/m1/s1
InChIKeyHVGCNNRBDRAISE-NISUVBJDSA-N
MW746.57 g/mol
LogP-1.32
Rot. Bonds2

About 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one

3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one (PubChem CID 137303418) has the molecular formula C22H24N10O12P2S2 and a molecular weight of 746.57 g/mol. Its IUPAC name is 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one.

Molecular Properties

Compound Name3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one
PubChem CID137303418
Molecular FormulaC22H24N10O12P2S2
Molecular Weight746.57 g/mol
Exact Mass746.05
IUPAC Name3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one
SMILESNc1nc2c(ncn2[C@@H]2O[C@@H]3COP(O)(=S)O[C@H]4[C@@H](O)[C@H](n5cnc6c(=O)n7ccnc7[nH]c65)O[C@@H]4COP(=O)(S)O[C@H]3[C@H]2O)c(=O)[nH]1
InChIInChI=1S/C22H24N10O12P2S2/c23-21-27-15-9(17(35)29-21)25-5-31(15)19-11(33)13-7(41-19)3-39-46(38,48)44-14-8(4-40-45(37,47)43-13)42-20(12(14)34)32-6-26-10-16(32)28-22-24-1-2-30(22)18(10)36/h1-2,5-8,11-14,19-20,33-34H,3-4H2,(H,24,28)(H,37,47)(H,38,48)(H3,23,27,29,35)/t7-,8-,11-,12-,13-,14-,19-,20-,45?,46?/m1/s1
InChIKeyHVGCNNRBDRAISE-NISUVBJDSA-N
XLogP-1.32
TPSA290.71 Ų
H-Bond Donors7
H-Bond Acceptors20
Rotatable Bonds2
Heavy Atoms48
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500746.57
LogP ≤ 5-1.32
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'}

Analyze 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one?
The IUPAC name of 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one (CID 137303418) is 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one.
What is the SMILES notation for 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one?
The canonical SMILES for 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one is Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(O)(=S)O[C@H]4[C@@H](O)[C@H](n5cnc6c(=O)n7ccnc7[nH]c65)O[C@@H]4COP(=O)(S)O[C@H]3[C@H]2O)c(=O)[nH]1.
What is the InChIKey of 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one?
The InChIKey is HVGCNNRBDRAISE-NISUVBJDSA-N. The full InChI is InChI=1S/C22H24N10O12P2S2/c23-21-27-15-9(17(35)29-21)25-5-31(15)19-11(33)13-7(41-19)3-39-46(38,48)44-14-8(4-40-45(37,47)43-13)42-20(12(14)34)32-6-26-10-16(32)28-22-24-1-2-30(22)18(10)36/h1-2,5-8,11-14,19-20,33-34H,3-4H2,(H,24,28)(H,37,47)(H,38,48)(H3,23,27,29,35)/t7-,8-,11-,12-,13-,14-,19-,20-,45?,46?/m1/s1.
What are the key properties of 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one?
3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one has a molecular weight of 746.57 g/mol, XLogP of -1.32, 2 rotatable bonds, 7 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-9,12,18-trihydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-4H-imidazo[1,2-a]purin-9-one is sourced from PubChem (CID 137303418), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).